Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 19,219 | 20,684 | 23,273 | 23,812 | 23,676 | 20,718 | 24,635 | 27,568 | 25,426 | 24,122 | | 24,122 |
% Growth | NA | 7.6% | 12.5% | 2.3% | -0.6% | -12.5% | 18.9% | 11.9% | -7.8% | -5.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | (15,625) | (16,750) | (18,567) | (19,111) | (18,971) | (16,770) | (19,739) | (21,817) | (20,148) | (19,421) | | (19,421) |
Gross Profit | 3,595 | 3,934 | 4,706 | 4,701 | 4,705 | 3,948 | 4,896 | 5,751 | 5,278 | 4,701 | | 4,701 |
% Revenue | 18.7% | 19.0% | 20.2% | 19.7% | 19.9% | 19.1% | 19.9% | 20.9% | 20.8% | 19.5% | | 19.5% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | (13) | (19) | (11) | (17) | (2) | (3) | (4) | (7) | | (7) |
Selling and Marketing | (1,922) | (2,093) | (2,592) | (2,527) | (2,532) | (2,190) | (2,556) | (3,106) | (2,841) | (2,668) | | (2,668) |
General and Admin | (839) | (938) | (1,117) | (1,114) | (1,180) | (1,162) | (1,262) | (1,466) | (1,515) | (1,466) | | (1,466) |
Other Inc / (Exp) | (140) | (105) | (127) | (182) | (121) | (185) | (42) | (27) | (100) | (308) | | (308) |
Total Operating Exp | (2,902) | (3,135) | (3,849) | (3,842) | (3,844) | (3,554) | (3,862) | (4,602) | (4,460) | (4,449) | | (4,449) |
| | | | | | | | | | | | |
Operating Income | 693 | 799 | 857 | 859 | 861 | 394 | 1,034 | 1,149 | 818 | 252 | | 252 |
% Revenue | 3.6% | 3.9% | 3.7% | 3.6% | 3.6% | 1.9% | 4.2% | 4.2% | 3.2% | 1.0% | | 1.0% |
| | | | | | | | | | | | |
Interest Expense | (11) | (13) | (19) | (42) | (42) | (30) | (16) | (23) | (56) | (62) | | (62) |
Pre-tax Income | 682 | 786 | 838 | 817 | 819 | 364 | 1,018 | 1,126 | 762 | 190 | | 190 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (164) | (198) | (207) | (109) | (213) | (60) | (250) | (197) | (138) | (67) | | (67) |
Net Income to Company | 519 | 588 | 631 | 708 | 606 | 304 | 768 | 929 | 624 | 123 | | 123 |
% Margin | 2.7% | 2.8% | 2.7% | 3.0% | 2.6% | 1.5% | 3.1% | 3.4% | 2.5% | 0.5% | | 0.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 519 | 588 | 631 | 708 | 606 | 304 | 768 | 929 | 624 | 123 | | 123 |
| | | | | | | | | | | | |
Preferred Dividends | (13) | (13) | (13) | (13) | (12) | (8) | (8) | (8) | (8) | (8) | | (8) |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 506 | 575 | 618 | 695 | 594 | 296 | 760 | 921 | 616 | 115 | | 115 |
% Margin | 2.6% | 2.8% | 2.7% | 2.9% | 2.5% | 1.4% | 3.1% | 3.3% | 2.4% | 0.5% | | 0.5% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 2.79 | 3.15 | 3.38 | 3.80 | 3.24 | 1.62 | 4.13 | 5.04 | 3.45 | 0.65 | | 0.65 |
Diluted EPS (Continuing Ops) | 2.76 | 3.13 | 3.36 | 3.79 | 3.23 | 1.61 | 4.10 | 5.02 | 3.43 | 0.65 | | 0.65 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 181.70 | 182.70 | 183.10 | 183.10 | 183.20 | 183.20 | 183.80 | 182.80 | 178.40 | 176.10 | | 176.10 |
WA Diluted Shares Out. | 183.30 | 183.80 | 184.00 | 183.50 | 183.90 | 184.20 | 185.20 | 183.50 | 179.50 | 177.10 | | 177.10 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 682 | 786 | 838 | 817 | 819 | 364 | 1,018 | 1,126 | 762 | 190 | | 190 |
Addback: Net Interest Expense | 11 | 13 | 19 | 42 | 42 | 30 | 16 | 23 | 56 | 62 | | 62 |
Addback: Other Non Operating Expenses, Total | 17 | (7) | 2 | (18) | (4) | (8) | (2) | (15) | 7 | 145 | | 145 |
Addback: Depreciation & Amortization | 172 | 134 | 176 | 171 | 171 | 162 | 104 | 83 | 100 | 101 | | 101 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 2 | 14 | 4 | 0 | 0 | 0 | 2 | 3 | 1 | 3 | | 3 |
Addback: Goodwill Impairment | 0 | 10 | 0 | 78 | 0 | 86 | 2 | 0 | 45 | 121 | | 121 |
Addback: Gain (Loss) On Sale Of Invest. | (7) | 1 | 0 | 0 | 0 | 0 | (35) | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 21 | 4 | 15 | 26 | 15 | 4 | 1 | | 1 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | (4) | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 878 | 946 | 1,039 | 1,111 | 1,048 | 649 | 1,131 | 1,235 | 975 | 623 | | 623 |
% Margin | 4.6% | 4.6% | 4.5% | 4.7% | 4.4% | 3.1% | 4.6% | 4.5% | 3.8% | 2.6% | | 2.6% |
| | | | | | | | | | | | |
Adjusted EBIT | 705 | 813 | 863 | 940 | 877 | 487 | 1,027 | 1,152 | 875 | 522 | | 522 |
% Margin | 3.7% | 3.9% | 3.7% | 3.9% | 3.7% | 2.4% | 4.2% | 4.2% | 3.4% | 2.2% | | 2.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 519 | 588 | 631 | 708 | 606 | 304 | 768 | 929 | 624 | 123 | | 123 |
Addback: Unusual Items | (5) | 21 | 4 | 99 | 20 | 101 | (5) | 18 | 50 | 125 | | 125 |
Less: Tax Benefit of Unusual Items (26%) | 1 | (5) | (1) | (26) | (5) | (26) | 1 | (5) | (13) | (33) | | (33) |
Adjusted Net Income | 515 | 603 | 634 | 781 | 621 | 379 | 764 | 942 | 661 | 216 | | 216 |
% Margin | 2.7% | 2.9% | 2.7% | 3.3% | 2.6% | 1.8% | 3.1% | 3.4% | 2.6% | 0.9% | | 0.9% |